ImmunityBio (IBRX) Price to FCF (2015 - 2026)
Powered by 
Analysis
ImmunityBio (IBRX) Price to FCF (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | ImmunityBio | 8.43 Bn | 8.07 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -131.77 |
| Mar 31, 2026 | -104.09 |
| Dec 31, 2025 | -28.12 |
| Sep 30, 2025 | -34.77 |
| Jun 30, 2025 | -29.91 |
| Mar 31, 2025 | -29.52 |
| Dec 31, 2024 | -20.46 |
| Sep 30, 2024 | -25.78 |
| Jun 30, 2024 | -42.88 |
| Mar 31, 2024 | -33.55 |
| Dec 31, 2023 | -20.72 |
| Sep 30, 2023 | -9.05 |
| Jun 30, 2023 | -15.77 |
| Mar 31, 2023 | -7.42 |
| Dec 31, 2022 | -19.49 |
| Sep 30, 2022 | -20.61 |
| Jun 30, 2022 | -13.81 |
| Mar 31, 2022 | -21.83 |
| Dec 31, 2021 | -29.48 |
| Sep 30, 2021 | -47.59 |